UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010643
Receipt number R000012448
Scientific Title Randomized multicenter study of the infection prevention comparing influenza vaccine to placebo for the summer epidemic of influenza in Okinawa
Date of disclosure of the study information 2013/05/08
Last modified on 2015/12/04 12:16:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized multicenter study of the infection prevention comparing influenza vaccine to placebo for the summer epidemic of influenza in Okinawa

Acronym

Study of the influenza vaccine for the summer epidemic of influenza

Scientific Title

Randomized multicenter study of the infection prevention comparing influenza vaccine to placebo for the summer epidemic of influenza in Okinawa

Scientific Title:Acronym

Study of the influenza vaccine for the summer epidemic of influenza

Region

Japan


Condition

Condition

influenza

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study will come out the effectiveness of the influenza HA vaccine for the summer epidemic of influenza in Okinawa. We desterilize the excess vaccine developed for the prevention to influenza in the last winter season.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The effect of the vaccine to prevent influenza for 3 years

Key secondary outcomes



Base

Study type


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Vaccine

Interventions/Control_1

Injection one time of the influenza vaccine subcutaneously.

Interventions/Control_2

Injection one time of saline subcutaneously.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) The doctor or the nurse engaging in the Internal or the pediatric, the emergency section
2) Enable to obtain the written informed consent.

Key exclusion criteria

1) Persons who have had the influenza within 8 weeks prior to the randomization.
2) Persons who have injected the influenza vaccine within 8 weeks prior to the randomization.
3) Persons who have have underlying disorder such as cardiac disorder, renal disorder, liver disorder, blood disorder or development disorders.
4) Pregnant female
5) Persons who have the risk of allergies to influenza vaccine.

Target sample size

440


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshihiro Takayama

Organization

Okinawa Chubu Hospital

Division name

Division of Infectious Diseases

Zip code


Address

281, Miyazato, Uruma, Okinawa, Japan

TEL

098-973-4111

Email

hiro-t@umin.net


Public contact

Name of contact person

1st name
Middle name
Last name Yoshihiro Takayama

Organization

Okinawa Chubu Hospital

Division name

Division of Infectious Diseases

Zip code


Address

281, Miyazato, Uruma, Okinawa

TEL

098-973-4111

Homepage URL


Email

hiro-t@umin.net


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

沖縄県立中部病院(沖縄県)、中頭病院(沖縄県)、沖縄徳洲会中部徳洲会病院(沖縄県)、ハートライフ病院(沖縄県)


Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 05 Month 16 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2016 Year 03 Month 31 Day

Date trial data considered complete

2016 Year 03 Month 31 Day

Date analysis concluded

2016 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 05 Month 03 Day

Last modified on

2015 Year 12 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012448


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name